| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 12.37B | 11.46B | 10.54B | 10.13B | 8.56B | 6.17B |
| Gross Profit | 5.90B | 5.46B | 5.05B | 4.84B | 4.21B | 2.96B |
| EBITDA | 1.50B | 1.65B | 1.58B | 1.15B | 1.30B | 867.70M |
| Net Income | 509.20M | 490.00M | 538.80M | 142.50M | 369.70M | 224.30M |
Balance Sheet | ||||||
| Total Assets | 10.09B | 9.95B | 8.05B | 8.02B | 7.07B | 5.16B |
| Cash, Cash Equivalents and Short-Term Investments | 531.00M | 731.00M | 1.15B | 1.58B | 1.31B | 964.40M |
| Total Debt | 3.71B | 3.74B | 2.61B | 2.45B | 2.37B | 2.10B |
| Total Liabilities | 6.88B | 6.58B | 5.18B | 5.39B | 4.73B | 3.67B |
| Stockholders Equity | 2.77B | 2.92B | 2.46B | 2.12B | 1.93B | 1.24B |
Cash Flow | ||||||
| Free Cash Flow | 830.60M | 713.00M | 611.30M | 735.00M | 1.02B | 938.30M |
| Operating Cash Flow | 1.29B | 1.23B | 1.14B | 1.08B | 1.27B | 1.06B |
| Investing Cash Flow | -673.80M | -1.49B | -543.50M | -320.90M | -848.10M | -334.70M |
| Financing Cash Flow | -998.70M | -141.00M | -1.01B | -479.20M | -83.60M | -239.70M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | £2.33B | 15.02 | 121.78% | 3.99% | 3.78% | 3.29% | |
73 Outperform | £2.98B | 6.42 | 19.54% | ― | -6.43% | 52.93% | |
71 Outperform | £4.10B | 8.51 | 19.64% | 1.21% | 14.60% | 58.84% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
60 Neutral | £828.80M | -4.74 | -18.75% | ― | -20.36% | 44.33% | |
59 Neutral | £352.35M | -1.21 | -81.34% | ― | -14.89% | 12.08% | |
46 Neutral | £296.13M | -1.41 | -172.24% | ― | -65.42% | 27.73% |